This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, R.
Right arrow Articles by de la Cruz, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, R.
Right arrow Articles by de la Cruz, F.
Related Collections
Right arrow Genetics & Dysmorphology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 6 December 2003, pp. 1519-1522


SUPPLEMENT ARTICLE

Research Design, Organization, and Sample Characteristics of the Maternal PKU Collaborative Study

Richard Koch, MD*, Colleen Azen, MS*, Eva Friedman, MS*, William Hanley, MD{ddagger}, Harvey Levy, MD§, Reuben Matalon, MD, PhD||, Bobbye Rouse, MD||, Friedrich Trefz, MD, Jiaping Ning, MS* and Felix de la Cruz, MD, MPH#

* Childrens Hospital Los Angeles, Division of Medical Genetics, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
{ddagger} Clinical and Biochemical Genetics, Hospital for Sick Children, Toronto, Ontario, Canada
§ Children’s Hospital Boston, Boston, Massachusetts
|| University of Texas Medical Branch, Department of Pediatrics/Genetics, Galveston, Texas
Childrens Hospital Reutlingen, Universität of Tubingen, Reutlingen, Germany
# National Institute of Child Health and Human Development, Bethesda, Maryland

Objective. The Maternal PKU Collaborative Study (MPKUCS) was initiated in 1984 by the National Institute of Child Health and Human Development (NICHD). The purpose was to assess the efficacy of dietary restriction of phenylalanine in reducing morbidity in offspring of women with hyperphenylalaninemia (HPA). A contract was awarded to Childrens Hospital Los Angeles as the Coordinating Center to provide implementation of the research protocol, data collection, and analysis.

Methods. The Study included four regional contributing centers: Childrens Hospital Los Angeles (Western Region), Boston Children’s Hospital (Northeast Region), University of Illinois (Midwest Region), and University of Texas Medical Branch, Galveston (Southeast Region). Within each region, many participating clinics were responsible for obstetric care, treatment, and monitoring protocols. In 1985, Canada joined the MPKUCS, and in 1992, Germany entered. They were selected because they provided dietary supplies and strong professional services. Acquisition began in 1984 and ended in October 1995. The study included 574 pregnancies in women with HPA and 100 control subjects matched on age, race, parity, and weeks of gestation. The sample included women with blood phenylalanine values >240 µmol/L, 66% of whom had classical PKU, 22% had atypical PKU, and 12% had mild HPA. Informed consents were obtained on all participants. The women ranged in age from 15 to 36 years of age, with a mean age at conception of 23 years. Teenage pregnancies accounted for 19%. Seventy-five percent graduated from high school. Offspring included 416 newborns, 317 of whom were evaluated at 4 years of age and 289 at 6 to 7 years. Follow-up involved medical, nutritional, psychosocial, and psychological assessments.

Conclusion. Women with PKU treated before conception and in control of their blood phenylalanine levels between 120 and 360 µmol/L (2–6 mg) exhibited normal pregnancies and neonatal outcome. Surprisingly, women who achieved control in the recommended range by 8 weeks of pregnancy also had a normal fetal outcome.


Abbreviations: PKU, phenylketonuria • NIH, National Institutes of Health • NICHD, National Institute of Child Health and Development • Phe, phenylalanine • HPA, hyperphenylalaninemia • MPKUCS, Maternal PKU Collaborative Study • WISC-R, Wechsler Intelligence Scale for Children–Revised



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
Committee on Genetics
Maternal Phenylketonuria
Pediatrics, August 1, 2008; 122(2): 445 - 449.
[Abstract] [Full Text] [PDF]